These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10641517)

  • 1. [Monitoring of clinical trials. Methodology, interim analyses, and end results].
    Pritsch M; Unnebrink K
    Med Klin (Munich); 1999 Dec; 94(12):712-7. PubMed ID: 10641517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monitoring clinical studies. Development, measures and consequences].
    Pritsch M; Unnebrink K
    Med Klin (Munich); 2000 May; 95(1 Spec No):72-6. PubMed ID: 10851852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard versus adaptive monitoring procedures: A commentary.
    Fleming TR
    Stat Med; 2006 Oct; 25(19):3305-12; discussion 3313-4, 3326-47. PubMed ID: 16850447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of clinical trials and interim analyses from a drug sponsor's point of view.
    Williams GW; Davis RL; Getson AJ; Gould AL; Hwang IK; Matthews H; Shih WJ; Snapinn SM; Walton-Bowen KL
    Stat Med; 1993 Mar; 12(5-6):481-92. PubMed ID: 8493426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for the interim analysis process: a case study.
    Delgado-Herrera L; Anbar D
    Control Clin Trials; 2003 Feb; 24(1):51-65. PubMed ID: 12559642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Information time scales for interim analyses of randomized clinical trials.
    Freidlin B; Othus M; Korn EL
    Clin Trials; 2016 Aug; 13(4):391-9. PubMed ID: 27136947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accounting for interim safety monitoring of an adverse event upon termination of a clinical trial.
    Dallas MJ
    J Biopharm Stat; 2008; 18(4):631-8; discussion 439-45. PubMed ID: 18607795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintaining confidentiality of interim data to enhance trial integrity and credibility.
    Fleming TR; Sharples K; McCall J; Moore A; Rodgers A; Stewart R
    Clin Trials; 2008; 5(2):157-67. PubMed ID: 18375654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Framework for Retrospective Assessment of Interim Decisions in Clinical Trials.
    Stanev R
    Med Decis Making; 2016 Nov; 36(8):999-1010. PubMed ID: 27353825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Termination rules in therapeutic trials. Application of sequential methods in 2 clinical trials in hematology].
    Bénichou J; Lepage E; Chastang C
    Nouv Rev Fr Hematol (1978); 1987; 29(1):87-91. PubMed ID: 3473443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Public clinical trials: which kind of monitoring should be used?].
    Cornu C; Binquet C; Thalamas C; Vigouroux C; Gaillard S; Ginhoux T; Vaz B; Jossan C; Félin A; Sailly A; Gueyffier F; Journot V; Kassaï B
    Therapie; 2013; 68(3):135-41. PubMed ID: 23886457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of interim analyses in drug development.
    Facey KM; Lewis JA
    Stat Med; 1998 Aug 15-30; 17(15-16):1801-9; discussion 1811-2. PubMed ID: 9749448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interim analyses in clinical trials.
    Emerson SS; Fleming TR
    Oncology (Williston Park); 1990 Mar; 4(3):126-33; discussion 134, 136. PubMed ID: 2144441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interim analysis in clinical trials: a methodological guide].
    Muñoz Navarro SR; Bangdiwala SI
    Rev Med Chil; 2000 Aug; 128(8):935-41. PubMed ID: 11129556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [When is enough evidence available?; interim analyses in clinical trials].
    van der Tweel Iv; Roes KC
    Ned Tijdschr Geneeskd; 2013; 157(12):A5660. PubMed ID: 23515039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory perspectives on data safety monitoring boards: protecting the integrity of data.
    Hemmings R; Day S
    Drug Saf; 2004; 27(1):1-6. PubMed ID: 14720083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical aspects in data monitoring: a brief review.
    Demets DL
    Stat Med; 1987; 6(7):753-60. PubMed ID: 3321314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interim analyses of data as they accumulate in laboratory experimentation.
    Ludbrook J
    BMC Med Res Methodol; 2003 Aug; 3():15. PubMed ID: 12930561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.